Burning Rock Biotech (Burning Rock Biotech) Market Cap : $73.36 Mil (As of May. 31, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Burning Rock Biotech's share price for the quarter that ended in Mar. 2024 was $7.281. Burning Rock Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 10.26 Mil. Therefore, Burning Rock Biotech's market cap for the quarter that ended in Mar. 2024 was $74.69 Mil.

Burning Rock Biotech's quarterly market cap declined from Sep. 2023 ($99.37 Mil) to Dec. 2023 ($95.27 Mil) and declined from Dec. 2023 ($95.27 Mil) to Mar. 2024 ($74.69 Mil).

Burning Rock Biotech's annual market cap declined from Dec. 2021 ($1,001.69 Mil) to Dec. 2022 ($230.95 Mil) and declined from Dec. 2022 ($230.95 Mil) to Dec. 2023 ($95.27 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Burning Rock Biotech's Enterprise Value for Today is $-3.52 Mil.

Burning Rock Biotech Market Cap Historical Data

The historical data trend for Burning Rock Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Market Cap Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

2,415.08

1,001.69

230.95

95.27

Burning Rock Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															288.52	220.75	99.37	95.27	74.69

Competitive Comparison of Burning Rock Biotech's Market Cap

For the Diagnostics & Research subindustry, Burning Rock Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's Market Cap falls into.

Burning Rock Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Burning Rock Biotech's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$9.3	*	10.244
	=	$95.27

Burning Rock Biotech's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	$7.281	*	10.2587
	=	$74.69

Burning Rock Biotech (NAS:BNR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Burning Rock Biotech Market Cap Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.